The subthalamic nucleus (STN) is a part of the basal ganglia (BG) and thus has a role in modulating voluntary motor function. Dysfunction of STN neuronal activity is thought to underlie a variety of movement disorders. For example, in Parkinson's disease (PD), abnormalities in STN activity correlate with motor deficits like resting tremor and rigidity (Hamani et al., 2004) . While surgical interventions aimed at physiologically restoring abnormal STN activity can work, these techniques are invasive and often ineffective (Wagle Shukla and Okun, 2014) . Therefore, studies identifying potential pharmacological targets that can alter STN neuronal activity are exciting. In a recent article published in The Journal of Neuroscience, Xiao et al. (2015) identified a novel BG microcircuit based on expression of nicotinic acetylcholine receptors (nAChR) in distinct neuronal subpopulations within the STN. The findings demonstrate the potential role of STN neurons expressing ␣4␤2-nAChRs in modulating neuronal activity in efferent targets.
Composed mainly of glutamatergic neurons, the STN primarily innervates the substantia nigra pars reticulata (SNr) and the globus pallidus internus (GPi). Both the SNr and the GPi contain GABAergic efferent neurons projecting to thalamocortical neurons, which in turn facilitate activation of motor cortex neurons. When STN neurons fire, they increase activation of GPi and SNr neurons, leading to greater thalamocortical inhibition and ultimately inhibition of motor function (Hamani et al., 2004) . The STN and the SNr also project to dopaminergic neurons in the substantia nigra pars compacta (SNc), but the functional relevance of this circuit in motor control is unclear (Hamani et al., 2004) .
Neurons in several of the aforementioned BGnucleiexpress␣4␤2nAChRs,␣7nAChRs, and ␣6␤2 nAChRs (Quik and Wonnacott, 2011) . Chronic nicotine treatment increases expression of ␣4␤2 nAChRs in the substantia nigra via posttranscriptional mechanisms (Marks et al., 1992) . This upregulation has been attributed to increased ␣4␤2-nAChR assembly and trafficking to the cell surface (Srinivasan et al., 2014) . In conjunction with increasing ␣4␤2-nAChR expression, chronic nicotine increases firing of SNr neurons, an effect that is correlated with increased suppression of SNc activity (Xiao et al., 2009 ). Because one of the primary afferents stimulating the SNr originate from neurons in the STN, Xiao et al. (2015) sought to examine the effects of chronic nicotine exposure on STN neuronal function. In doing so, they identified novel subpopulations of nAChR-expressing neurons in the STN and mapped their functional connections to the SNr and the SNc. Xiao et al. (2015) first examined nAChR expression in STN neurons by focally applying acetylcholine (ACh). They observed two distinct ACh-evoked responses in STN neurons. One subpopulation of neurons exhibited an ACh-evoked current characterized by fast activation and fast decay kinetics while another subpopulation exhibited an ACh-evoked current characterized by fast activation but slow decay kinetics. Treatment with the ␣7-nAChR antagonist, MLA, completely abolished AChevoked responses in neurons exhibiting a fast decaying current. Treatment with the ␤2-nAChR antagonist DH␤E completely abolished ACh-evoked responses in neurons exhibiting a slow decaying current. From these experiments, it was concluded that ␣7-nAChRs and ␣4␤2-nAChRs are expressed in distinct subpopulations of STN neurons.
Synaptic activity in the STN is modulated by inhibitory GABAergic inputs from the globus pallidus externus (GPe) as well as excitatory glutamatergic inputs from the motor cortex (Hamani et al., 2004) . Therefore, Xiao et al. (2015) assessed the density of inhibitory and excitatory afferents innervating neurons expressing ␣4␤2-or ␣7-nAChRs. Analysis of spontaneousandevokedexcitatoryandinhib-itory postsynaptic events indicated that neurons expressing ␣4␤2-nAChRs received a greater proportion of glutamatergic inputs whereas neurons expressing ␣7-nAChRs received a greater proportion of GABAergic input. Though not directly assessed, these findings suggest neurons expressing ␣4␤2-nAChRs receive a larger proportion of inputs from the motor cortex while neurons expressing ␣7-nAChRs receive a greater proportion of inputs from the GPe. The differing inputs to theneuronalsubpopulationssuggestthatSTN neurons expressing ␣4␤2-nAChRs or ␣7-nAChRs have different roles in BG motor circuitry.
The STN is part of the hyperdirect and indirect motor pathways of the BG, which are distinguished by the origin of inputs to the STN (Nambu et al., 2002) . The hyperdirect pathway involves direct glutamatergic inputs from the motor cortex to the STN. These cortical afferents activate the STN, which, through its efferent targets to BG output nuclei, inhibit thalamocortical neurons regulating motor cortex output. The STN neurons expressing ␣4␤2-nAChRs, which receive a larger proportion of glutamatergic innervations, may therefore be part of the hyperdirect pathway. STN neurons in the indirect pathway receive GABAergic inputs from the GPe. Activation of this pathway is thought to stop movements that have been activated (Nambu et al., 2002) . The current findings, highlighting a stronger innervation of neurons expressing ␣7-nAChRs by GABAergic inputs, suggest that these cells may be more strongly associated with the indirect pathway. Further conclusions on the potential role of neurons expressing ␣4␤2-and ␣7-nAChRs in mediating voluntary movements would be strengthened by studies highlighting the origin and density of inputs to these neurons.
To further characterize the circuitry involving STN neurons expressing ␣4␤2-or ␣7-nAChRs, Xiao et al. (2015) measured spontaneous EPSCs (sEPSC) in SNr and SNc neurons following activation of these nicotinic receptors. After demonstrating STN outputs to the SNr and SNc remained intact in slice preparations, the authors showed focal perfusion of an ␣4␤2-nAChR agonist in the STN increased sEPSC frequency in SNr neurons without detectably changing sEPSC frequency in SNc neurons. In contrast, application of an ␣7-nAChR agonist in the STN resulted in a greater increase of sEPSC frequency in SNc than SNr neurons. The authors therefore proposed that STN neurons expressing ␣4␤2-nAChRs preferentially project to the SNr while STN neurons expressing ␣7-nAChRs preferentially project to the SNc.
Previous findings by Xiao et al. (2009) showed that chronic nicotine treatment increased SNr firing and subsequently suppressed SNc activity. In light of this and their new discovery that STN neurons expressing ␣4␤2-nAChRs innervate the SNr, Xiao et al. (2015) went on to examine the effects of chronic nicotine on ␣4␤2-nAChR expression and the corresponding changes in neuronal activity in the STN. Chronic nicotine treatment increased ␣4␤2 nAChR expression and increased the percentage of STN neurons expressing ␣4␤2 nAChRs. Further analysis of STN neuronal activity both in vivo and in vitro showed increased firing of STN neurons expressing ␣4␤2-but not ␣7-nAChRs following chronic nicotine treatment. Thus, the current findings extend those of Xiao et al. (2009) by suggesting that the increase in activity of SNr neurons following chronic nicotine exposure may result from increased activity of STN neurons that express ␣4␤2-nAChRs and synapse onto SNr cells. Though plausible, experiments are still needed to bolster this conclusion by determining whether increased activity in the SNr caused by chronic nicotine depends on changes in ␣4␤2-nAChR function within STN neurons. Chronic nicotine also resulted in increased GABA release onto SNc dopaminergic neurons, presumably the result of increased activity of SNr neurons (Xiao et al., 2009 ). Because dopamine cell loss during PD is believed to occur, in part, through increased excitotoxicity (Caudle and Zhang, 2009) , targeting ␣4␤2-nAChRs may represent a useful therapeutic for reducing dopaminergic cell loss.
The chronic nicotine experiments performed by Xiao et al. (2015) suggest that targeting ␣4␤2-nAChRs within the STN could be used to treat involuntary movement disorders by increasing STN activity. For instance, levodopa-induced dyskinesias during PD are thought to result from reduced activity in the STN (Hamani et al., 2004) . This would result in decreased activity of downstream GABAergic neurons in the SNr and GPi, leading to a facilitation of thalamocortical motor pathways that may cause dyskinesias. Nicotine has been demonstrated to be effective in alleviating levodopa-induced dyskinesias in a PD model in monkeys, which could be a result of increased STN activity (Quik et al., 2007) . Results from Xiao et al. (2009) and Xiao et al. (2015) support this hypothesis, in that chronic nicotine was demonstrated to concurrently enhance activity in the STN and its downstream target in the SNr. However, targeting ␣4␤2-nAChRs may only work if there is a connection between STN neurons expressing ␣4␤2-nAChRs and the GPi. Thus, future studies should investigate whether such a connection exists. Additionally, it should be determined whether ␣4␤2-selective agonists mimic the effects of nicotine by upregulating ␣4␤2-nAChRs within the STN. Using a selective agonist could reduce some off-target effects of nicotine.
The findings of Xiao et al. (2015) highlight a novel microcircuit based on differential expression of nAChRs on STN neurons. These findings suggest that targeting ␣4␤2-nAChRs may have therapeutic implications for treating PD and other motor disorders.
